Welcome to our dedicated page for ETRACS Whitney US Critical Techs ETN SEC filings (Ticker: WUCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ETRACS Whitney US Critical Techs ETN's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ETRACS Whitney US Critical Techs ETN's regulatory disclosures and financial reporting.
Transaction overview: UBS AG is issuing $777,000 of unsubordinated, unsecured Trigger Autocallable Contingent Yield Notes linked to the common stock of The Kraft Heinz Company (KHC). The notes price on 11 Jul 2025, settle on 15 Jul 2025 and mature on 17 Jul 2028, unless called earlier.
- Face amount: $10 per note (minimum purchase 100 notes).
- Contingent coupon: 8.68% p.a. (paid quarterly ≈ $0.217 per note) only when KHC closes ≥ coupon barrier on an observation date.
- Coupon barrier / downside threshold: $19.00 (70% of initial level $27.14).
- Automatic call: Beginning 6 months after settlement and quarterly thereafter, if KHC closes ≥ initial level ($27.14). Investors receive par + any due coupon; no further payments.
- Principal at maturity: • Par if KHC ≥ downside threshold and notes were not called. • Par × (1 + underlying return) if KHC < threshold, resulting in 1-for-1 downside exposure to −100%.
- Estimated initial value: $9.62 (UBS internal model), 3.8% below issue price due to fees/hedging costs.
- Secondary market: No listing; UBS affiliates may make markets but are not obliged to do so.
Key risks highlighted by issuer:
- Loss of up to full principal if KHC falls >30% and notes are not called.
- Coupons contingent; investors may receive few or none.
- Credit risk of UBS AG senior debt.
- Potential illiquidity and bid–ask premium in secondary trading.
- Estimated value below issue price; early resale likely below $10.
Illustrative performance scenarios: UBS shows (1) early call after two quarters producing a 4.34% total return; (2) hold to maturity with KHC ≥ threshold producing same 4.34% total return; (3) KHC down 33.5% at maturity producing a 31.3% loss.
Use-of-proceeds & distribution: UBS Securities LLC will purchase the notes less a $0.20 per-note underwriting discount and resell to UBS Financial Services Inc.; the offering raises net proceeds of ≈ $761,460 for UBS. Because both dealers are UBS affiliates, the deal is a FINRA 5121 conflict-of-interest offering.
Investor suitability: Product targets investors comfortable with (i) single-name equity risk, (ii) contingent income, (iii) potential illiquidity, and (iv) UBS credit exposure. Not appropriate for investors seeking principal protection, guaranteed income, or equity upside participation.
Transaction overview: UBS AG is issuing $777,000 of unsubordinated, unsecured Trigger Autocallable Contingent Yield Notes linked to the common stock of The Kraft Heinz Company (KHC). The notes price on 11 Jul 2025, settle on 15 Jul 2025 and mature on 17 Jul 2028, unless called earlier.
- Face amount: $10 per note (minimum purchase 100 notes).
- Contingent coupon: 8.68% p.a. (paid quarterly ≈ $0.217 per note) only when KHC closes ≥ coupon barrier on an observation date.
- Coupon barrier / downside threshold: $19.00 (70% of initial level $27.14).
- Automatic call: Beginning 6 months after settlement and quarterly thereafter, if KHC closes ≥ initial level ($27.14). Investors receive par + any due coupon; no further payments.
- Principal at maturity: • Par if KHC ≥ downside threshold and notes were not called. • Par × (1 + underlying return) if KHC < threshold, resulting in 1-for-1 downside exposure to −100%.
- Estimated initial value: $9.62 (UBS internal model), 3.8% below issue price due to fees/hedging costs.
- Secondary market: No listing; UBS affiliates may make markets but are not obliged to do so.
Key risks highlighted by issuer:
- Loss of up to full principal if KHC falls >30% and notes are not called.
- Coupons contingent; investors may receive few or none.
- Credit risk of UBS AG senior debt.
- Potential illiquidity and bid–ask premium in secondary trading.
- Estimated value below issue price; early resale likely below $10.
Illustrative performance scenarios: UBS shows (1) early call after two quarters producing a 4.34% total return; (2) hold to maturity with KHC ≥ threshold producing same 4.34% total return; (3) KHC down 33.5% at maturity producing a 31.3% loss.
Use-of-proceeds & distribution: UBS Securities LLC will purchase the notes less a $0.20 per-note underwriting discount and resell to UBS Financial Services Inc.; the offering raises net proceeds of ≈ $761,460 for UBS. Because both dealers are UBS affiliates, the deal is a FINRA 5121 conflict-of-interest offering.
Investor suitability: Product targets investors comfortable with (i) single-name equity risk, (ii) contingent income, (iii) potential illiquidity, and (iv) UBS credit exposure. Not appropriate for investors seeking principal protection, guaranteed income, or equity upside participation.
Transaction overview: UBS AG is issuing $777,000 of unsubordinated, unsecured Trigger Autocallable Contingent Yield Notes linked to the common stock of The Kraft Heinz Company (KHC). The notes price on 11 Jul 2025, settle on 15 Jul 2025 and mature on 17 Jul 2028, unless called earlier.
- Face amount: $10 per note (minimum purchase 100 notes).
- Contingent coupon: 8.68% p.a. (paid quarterly ≈ $0.217 per note) only when KHC closes ≥ coupon barrier on an observation date.
- Coupon barrier / downside threshold: $19.00 (70% of initial level $27.14).
- Automatic call: Beginning 6 months after settlement and quarterly thereafter, if KHC closes ≥ initial level ($27.14). Investors receive par + any due coupon; no further payments.
- Principal at maturity: • Par if KHC ≥ downside threshold and notes were not called. • Par × (1 + underlying return) if KHC < threshold, resulting in 1-for-1 downside exposure to −100%.
- Estimated initial value: $9.62 (UBS internal model), 3.8% below issue price due to fees/hedging costs.
- Secondary market: No listing; UBS affiliates may make markets but are not obliged to do so.
Key risks highlighted by issuer:
- Loss of up to full principal if KHC falls >30% and notes are not called.
- Coupons contingent; investors may receive few or none.
- Credit risk of UBS AG senior debt.
- Potential illiquidity and bid–ask premium in secondary trading.
- Estimated value below issue price; early resale likely below $10.
Illustrative performance scenarios: UBS shows (1) early call after two quarters producing a 4.34% total return; (2) hold to maturity with KHC ≥ threshold producing same 4.34% total return; (3) KHC down 33.5% at maturity producing a 31.3% loss.
Use-of-proceeds & distribution: UBS Securities LLC will purchase the notes less a $0.20 per-note underwriting discount and resell to UBS Financial Services Inc.; the offering raises net proceeds of ≈ $761,460 for UBS. Because both dealers are UBS affiliates, the deal is a FINRA 5121 conflict-of-interest offering.
Investor suitability: Product targets investors comfortable with (i) single-name equity risk, (ii) contingent income, (iii) potential illiquidity, and (iv) UBS credit exposure. Not appropriate for investors seeking principal protection, guaranteed income, or equity upside participation.
Transaction overview: UBS AG is issuing $777,000 of unsubordinated, unsecured Trigger Autocallable Contingent Yield Notes linked to the common stock of The Kraft Heinz Company (KHC). The notes price on 11 Jul 2025, settle on 15 Jul 2025 and mature on 17 Jul 2028, unless called earlier.
- Face amount: $10 per note (minimum purchase 100 notes).
- Contingent coupon: 8.68% p.a. (paid quarterly ≈ $0.217 per note) only when KHC closes ≥ coupon barrier on an observation date.
- Coupon barrier / downside threshold: $19.00 (70% of initial level $27.14).
- Automatic call: Beginning 6 months after settlement and quarterly thereafter, if KHC closes ≥ initial level ($27.14). Investors receive par + any due coupon; no further payments.
- Principal at maturity: • Par if KHC ≥ downside threshold and notes were not called. • Par × (1 + underlying return) if KHC < threshold, resulting in 1-for-1 downside exposure to −100%.
- Estimated initial value: $9.62 (UBS internal model), 3.8% below issue price due to fees/hedging costs.
- Secondary market: No listing; UBS affiliates may make markets but are not obliged to do so.
Key risks highlighted by issuer:
- Loss of up to full principal if KHC falls >30% and notes are not called.
- Coupons contingent; investors may receive few or none.
- Credit risk of UBS AG senior debt.
- Potential illiquidity and bid–ask premium in secondary trading.
- Estimated value below issue price; early resale likely below $10.
Illustrative performance scenarios: UBS shows (1) early call after two quarters producing a 4.34% total return; (2) hold to maturity with KHC ≥ threshold producing same 4.34% total return; (3) KHC down 33.5% at maturity producing a 31.3% loss.
Use-of-proceeds & distribution: UBS Securities LLC will purchase the notes less a $0.20 per-note underwriting discount and resell to UBS Financial Services Inc.; the offering raises net proceeds of ≈ $761,460 for UBS. Because both dealers are UBS affiliates, the deal is a FINRA 5121 conflict-of-interest offering.
Investor suitability: Product targets investors comfortable with (i) single-name equity risk, (ii) contingent income, (iii) potential illiquidity, and (iv) UBS credit exposure. Not appropriate for investors seeking principal protection, guaranteed income, or equity upside participation.
Transaction overview: UBS AG is issuing $777,000 of unsubordinated, unsecured Trigger Autocallable Contingent Yield Notes linked to the common stock of The Kraft Heinz Company (KHC). The notes price on 11 Jul 2025, settle on 15 Jul 2025 and mature on 17 Jul 2028, unless called earlier.
- Face amount: $10 per note (minimum purchase 100 notes).
- Contingent coupon: 8.68% p.a. (paid quarterly ≈ $0.217 per note) only when KHC closes ≥ coupon barrier on an observation date.
- Coupon barrier / downside threshold: $19.00 (70% of initial level $27.14).
- Automatic call: Beginning 6 months after settlement and quarterly thereafter, if KHC closes ≥ initial level ($27.14). Investors receive par + any due coupon; no further payments.
- Principal at maturity: • Par if KHC ≥ downside threshold and notes were not called. • Par × (1 + underlying return) if KHC < threshold, resulting in 1-for-1 downside exposure to −100%.
- Estimated initial value: $9.62 (UBS internal model), 3.8% below issue price due to fees/hedging costs.
- Secondary market: No listing; UBS affiliates may make markets but are not obliged to do so.
Key risks highlighted by issuer:
- Loss of up to full principal if KHC falls >30% and notes are not called.
- Coupons contingent; investors may receive few or none.
- Credit risk of UBS AG senior debt.
- Potential illiquidity and bid–ask premium in secondary trading.
- Estimated value below issue price; early resale likely below $10.
Illustrative performance scenarios: UBS shows (1) early call after two quarters producing a 4.34% total return; (2) hold to maturity with KHC ≥ threshold producing same 4.34% total return; (3) KHC down 33.5% at maturity producing a 31.3% loss.
Use-of-proceeds & distribution: UBS Securities LLC will purchase the notes less a $0.20 per-note underwriting discount and resell to UBS Financial Services Inc.; the offering raises net proceeds of ≈ $761,460 for UBS. Because both dealers are UBS affiliates, the deal is a FINRA 5121 conflict-of-interest offering.
Investor suitability: Product targets investors comfortable with (i) single-name equity risk, (ii) contingent income, (iii) potential illiquidity, and (iv) UBS credit exposure. Not appropriate for investors seeking principal protection, guaranteed income, or equity upside participation.
Accenture plc (ACN) – Form 144 filing: The notice discloses that Julie Sweet intends to sell 2,251 Class A ordinary shares through UBS Financial Services on or about 11 July 2025. The aggregate market value of the planned sale is $646,509.71. During the last three months, Sweet sold 13,574 shares in three separate transactions, generating $4.997 million in gross proceeds. The proposed sale represents less than 0.001% of Accenture’s 680.3 million shares outstanding. The shares being sold were acquired via stock-award grants on 5 December 2023 (2,136 shares) and 5 January 2024 (115 shares). No other financial metrics or company-wide developments are provided in this filing.
Accenture plc (ACN) – Form 144 filing: The notice discloses that Julie Sweet intends to sell 2,251 Class A ordinary shares through UBS Financial Services on or about 11 July 2025. The aggregate market value of the planned sale is $646,509.71. During the last three months, Sweet sold 13,574 shares in three separate transactions, generating $4.997 million in gross proceeds. The proposed sale represents less than 0.001% of Accenture’s 680.3 million shares outstanding. The shares being sold were acquired via stock-award grants on 5 December 2023 (2,136 shares) and 5 January 2024 (115 shares). No other financial metrics or company-wide developments are provided in this filing.
Accenture plc (ACN) – Form 144 filing: The notice discloses that Julie Sweet intends to sell 2,251 Class A ordinary shares through UBS Financial Services on or about 11 July 2025. The aggregate market value of the planned sale is $646,509.71. During the last three months, Sweet sold 13,574 shares in three separate transactions, generating $4.997 million in gross proceeds. The proposed sale represents less than 0.001% of Accenture’s 680.3 million shares outstanding. The shares being sold were acquired via stock-award grants on 5 December 2023 (2,136 shares) and 5 January 2024 (115 shares). No other financial metrics or company-wide developments are provided in this filing.
Accenture plc (ACN) – Form 144 filing: The notice discloses that Julie Sweet intends to sell 2,251 Class A ordinary shares through UBS Financial Services on or about 11 July 2025. The aggregate market value of the planned sale is $646,509.71. During the last three months, Sweet sold 13,574 shares in three separate transactions, generating $4.997 million in gross proceeds. The proposed sale represents less than 0.001% of Accenture’s 680.3 million shares outstanding. The shares being sold were acquired via stock-award grants on 5 December 2023 (2,136 shares) and 5 January 2024 (115 shares). No other financial metrics or company-wide developments are provided in this filing.
Accenture plc (ACN) – Form 144 filing: The notice discloses that Julie Sweet intends to sell 2,251 Class A ordinary shares through UBS Financial Services on or about 11 July 2025. The aggregate market value of the planned sale is $646,509.71. During the last three months, Sweet sold 13,574 shares in three separate transactions, generating $4.997 million in gross proceeds. The proposed sale represents less than 0.001% of Accenture’s 680.3 million shares outstanding. The shares being sold were acquired via stock-award grants on 5 December 2023 (2,136 shares) and 5 January 2024 (115 shares). No other financial metrics or company-wide developments are provided in this filing.
FAQ
What is the current stock price of ETRACS Whitney US Critical Techs ETN (WUCT)?
